NasdaqGM - Nasdaq Real Time Price ? USD LeMaitre Vascular, Inc. (LMAT) Follow Compare 85.64 -0.94 (-1.09%) At close: October 25 at 4:00 PM EDT 85.64 0.00 (0.00%) After hours: October 25 at 4:02 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations BAX or LMAT: Which Is the Better Value Stock Right Now? BAX vs. LMAT: Which Stock Is the Better Value Option? Zacks ? 8 days ago LMAT -1.09% BAX LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them GlobeNewswire ? 11 days ago LMAT -1.09% LeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ... LeMaitre Vascular Inc (LMAT) reports impressive Q2 2024 results with significant sales and EPS growth, while navigating regulatory and operational challenges. GuruFocus.com ? 17 days ago LMAT -1.09% BAX vs. LMAT: Which Stock Is the Better Value Option? BAX vs. LMAT: Which Stock Is the Better Value Option? Zacks ? 24 days ago LMAT -1.09% BAX LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals? LeMaitre Vascular's (NASDAQ:LMAT) stock is up by a considerable 14% over the past three months. Since the market... Simply Wall St. ? 27 days ago LMAT -1.09% All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy LeMaitre (LMAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Zacks ? last month LMAT -1.09% LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the small-cap growth market was down. Higher quality, earners, and larger small caps were among the traits of many of the stocks […] Insider Monkey ? last month LMAT -1.09% Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)? LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), is not the largest company out there, but it saw a decent share price growth... Simply Wall St. ? last month LMAT -1.09% LeMaitre Vascular (NASDAQ:LMAT) shareholders have earned a 25% CAGR over the last five years When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose... Simply Wall St. ? last month LMAT -1.09% Acadia Healthcare Expands Behavioral Health Services in Iowa ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System. Zacks ? last month ACHC AVNS LMAT -1.09% LeMaitre to Participate at Upcoming Investor Conferences in September BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September. Morgan Stanley 22nd Annual Global Healthcare ConferenceWednesday, September 4, 2024New York Marriott Marquis, New York, NYDavid Roberts, President, will present at 5:35 PM EST Barrington Research Fall Investment Conference (Virtual)Thursday, September 12, 2024George W. LeMaitre, Chairman & CEO, is sch GlobeNewswire ? last month LMAT -1.09% LeMaitre Vascular's (NASDAQ:LMAT) Returns Have Hit A Wall To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd... Simply Wall St. ? 2 months ago LMAT -1.09% Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2 Conestoga Capital Advisors, an asset management company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The second quarter of 2024 may be regarded as a time of moderation. Economic indicators largely reflected slowing growth and easing inflation. Equity markets are also driven by the moderation theme. […] Insider Monkey ? 2 months ago LMAT -1.09% ^RUT LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). Zacks ? 2 months ago LMAT -1.09% Best Momentum Stock to Buy for August 6th HWKN, PPC and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 6, 2024. Zacks ? 2 months ago LMAT -1.09% PPC LeMaitre Vascular Second Quarter 2024 Earnings: Beats Expectations LeMaitre Vascular ( NASDAQ:LMAT ) Second Quarter 2024 Results Key Financial Results Revenue: US$55.8m (up 11% from 2Q... Simply Wall St. ? 2 months ago LMAT -1.09% LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates LeMaitre (LMAT) delivered earnings and revenue surprises of 10.64% and 1.25%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago LMAT -1.09% LeMaitre: Q2 Earnings Snapshot LMAT) on Thursday reported second-quarter profit of $11.8 million. The Burlington, Massachusetts-based company said it had profit of 52 cents per share. The results beat Wall Street expectations. Associated Press Finance ? 2 months ago LMAT -1.09% LeMaitre Q2 2024 Financial Results BURLINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q2 2024 Financial Results Sales $55.8mm, +11% (+12% organic) vs. Q2 2023 Gross margin 68.9%, +490 bpsOp. income $14.4mm, +52%Op. margin 26%Net income $11.8mm, +46%Earnings per diluted share $0.52, +44%Cash up $4.8mm sequentially to $113.1mm Allografts (+30%), bovine pat GlobeNewswire ? 2 months ago LMAT -1.09% HLN vs. LMAT: Which Stock Is the Better Value Option? HLN vs. LMAT: Which Stock Is the Better Value Option? Zacks ? 3 months ago LMAT -1.09% HLN Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return LMAT S&P 500 YTD +51.85% +21.77% 1-Year +74.52% +36.74% 3-Year +62.94% +27.79%
